Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

When trying to lose weight, avoid extreme restrictions or punishing workouts. Instead, focus on balance, patience, and ...

But how much walking do you really need to do to lose weight? It would be great if there were a set number. Then you could ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Ferreira, who is 43 years old, pointed out that losing weight doesn’t get any easier with age. “Factor in genetics, surgeries ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.